Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Liver metastasis and resistance to immunotherapy in microsatellite stable colorectal cancer. A literature review

18 Sept 2024

Abstract excerpt

Background: Microsatellite stable (MSS) metastatic colorectal cancer (CRC) remains predominantly managed with chemotherapy. The use of immunotherapy, whether alone or in combination with other systemic or local treatments, displays limited success, especially in the context of active liver metastases (LM). The mechanisms responsible for this resistance are not fully understood. Methods: We conducted a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Colorectal Cancer Treatments and Studies
Share to Hepatocellular Carcinoma Treatment and Prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39430087
DOI: 10.3332/ecancer.2024.1771

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Liver metastasis and resistance to immunotherapy in microsatellite stable colorectal cancer. A literature reviewPMID 39430087Read ↗

Effect of Liver Metastases on Survival in Microsatellite-Stable Metastatic Colorectal Cancer Treated with Immune Checkpoint Inhibitors.Semantic proximity Read ↗

Immunotherapy of microsatellite stable colorectal cancer: resistance mechanisms and treatment strategies.Semantic proximity Read ↗

Unraveling Resistance to Immunotherapy in MSI-High Colorectal CancerSemantic proximity Read ↗

How to overcome resistance to immune checkpoint inhibitors in colorectal cancer: From mechanisms to translationSemantic proximity Read ↗

Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistanceSemantic proximity Read ↗

Molecular Subtypes, microRNAs and Immunotherapy Response in Metastatic Colorectal CancerSemantic proximity Read ↗

Colorectal cancer patients-derived immunity-organoid platform unveils cancer-specific tissue markers associated with immunotherapy resistanceSemantic proximity Read ↗

Immunotherapy for the treatment of colorectal cancerSemantic proximity Read ↗

The Resistance Mechanisms of Checkpoint Inhibitors in Solid TumorsSemantic proximity Read ↗

Immune Checkpoint Inhibition in Metastatic Colorectal Cancer Harboring Microsatellite Instability or Mismatch Repair DeficiencySemantic proximity Read ↗

Beyond Microsatellite Instability: Evolving Strategies Integrating Immunotherapy for Microsatellite Stable Colorectal CancerSemantic proximity Read ↗

Immunotherapy in Colorectal Cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.